543594 — Dipna Pharmachem Balance Sheet
0.000.00%
- IN₹494.85m
- IN₹665.27m
- IN₹1.64bn
- 23
- 58
- 93
- 63
Annual balance sheet for Dipna Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 1.78 | 2.53 | 2.09 | 56.9 | 139 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 127 | 173 | 297 | 285 | 309 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 184 | 248 | 362 | 775 | 1,329 |
Net Property, Plant And Equipment | 0.427 | 0.406 | 0.412 | 0.396 | 0.372 |
Other Long Term Assets | |||||
Total Assets | 184 | 248 | 362 | 776 | 1,329 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 145 | 205 | 312 | 390 | 828 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 179 | 242 | 345 | 532 | 954 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 5.47 | 5.72 | 17.4 | 244 | 375 |
Total Liabilities & Shareholders' Equity | 184 | 248 | 362 | 776 | 1,329 |
Total Common Shares Outstanding |